Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
Maruapula D, Moraka NO, Bareng OT, Mokgethi PT, Choga WT, Seatla KK, Kelentse N, Koofhethille CK, Zuze BJL, Gaolathe T, Pretorius-Holme M, Makhema J, Novitsky V, Shapiro R, Moyo S, Lockman S, Gaseitsiwe S.
Maruapula D, et al. Among authors: gaseitsiwe s.
J Antimicrob Chemother. 2023 Oct 3;78(10):2489-2495. doi: 10.1093/jac/dkad258.
J Antimicrob Chemother. 2023.
PMID: 37585352
Free PMC article.